Michael Barbella is a Freelance Writer at various publications. He specializes in themes related to medicine and healthcare, including diagnostics, healthcare systems, alternative medicine, and medical technology, while also covering business and economics. Michael's work has been featured in Orthopedic Design & Technology and Medical Product Outsourcing.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Michael Barbella's work predominantly focuses on reporting press releases and private sector announcements related to medical devices, healthcare technology, clinical trials, FDA approvals, and medical research. He would likely be interested in receiving pitches concerning new product launches or updates within the healthcare and pharmaceutical industries.
Given his coverage attributes, Michael may respond well to pitches that involve exclusive data or insights from industry experts regarding advancements in medical devices or innovations in healthcare technology. Additionally, providing access to key opinion leaders or executives for interviews could also be an effective approach for reaching out to him.
Although no specific geographic focus is mentioned, it can be assumed that Michael covers global developments in the healthcare and pharmaceutical sectors due to the nature of the topics he reports on.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Michael Barbella
Vista Cardiac image acquisition software automates and simplifies CMR scans. January 23, 2025
Money will help the company advance its commercialization trajectory. January 23, 2025
By: Michael Barbella
Serbanich has more than 25 years of experience leading controllership and financial functions at startups and global companies. January 23, 2025
By: Michael Barbella
Results may potentially drive further adoption of Focal One as a first line treatment option for localized prostate cancer. January 23, 2025
By: Michael Barbella
Proprietary technology designed to accommodate higher-acuity patients and deliver exceptional performance. January 23, 2025
By: Michael Barbella
The plates are available in thicknesses of 2 mm, 2.4 mm, 2.6 mm, and 2.8 mm. January 24, 2025
By: Michael Barbella
Company expects to submit an IDE and begin a clinical trial in the second half of the year. January 24, 2025
By: Michael Barbella
IOPS was designed without the need for prolonged fluoroscopy during endovascular procedures. January 24, 2025
Company's AI-powered, FDA-cleared technology supports non-invasive CT imaging for improved coronary artery disease treatment. January 24, 2025
By: Michael Barbella
MicroWash is a less invasive alternative to nasal swab. January 24, 2025
(833) 317-6278 
